Related Experiment Videos
Muscle-based gene therapy: realistic possibilities for the future
E C Svensson1, S K Tripathy, J M Leiden
1Section of Cardiology, University of Chicago, IL 60637, USA.
Molecular Medicine Today
|April 1, 1996
Summary
Gene therapy shows promise for treating diseases like cancer and atherosclerosis. This review explores using skeletal muscle for gene delivery, detailing vectors, targets, and challenges for human applications.
Area of Science:
- Biomedical research
- Molecular biology
- Regenerative medicine
Background:
- Gene therapy has rapidly advanced in the last five years.
- Pre-clinical and clinical trials target diverse diseases including cancer, AIDS, and atherosclerosis.
- Various vectors and target organs are employed for therapeutic gene delivery.
Purpose of the Study:
- To review the rationale for utilizing skeletal muscle as a gene therapy target.
- To discuss the diverse vectors used in muscle-based gene therapy.
- To summarize disease targets and challenges in human skeletal muscle gene therapy.
Main Methods:
- Literature review of gene therapy studies.
- Analysis of vector systems for skeletal muscle gene delivery.
- Examination of disease applications and therapeutic outcomes.
Main Results:
- Skeletal muscle offers a viable target tissue for gene therapy.
- A broad range of viral and non-viral vectors have been investigated for muscle-based delivery.
- Gene therapy approaches have been applied to various genetic and acquired diseases.
Conclusions:
- Skeletal muscle gene therapy holds significant therapeutic potential.
- Overcoming current obstacles is crucial for successful clinical translation.
- Further research is needed to optimize vector efficiency and safety for human applications.